Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Radiation Oncology
•
Thoracic Malignancies
What would be your post-operative therapy approach for a high grade neuroendocrine carcinoma of the thymus?
What if there was mediastinal nodal involvement?
Answer from: Radiation Oncologist at Academic Institution
Postoperative RT.
Sign in or Register to read more
13071
Related Questions
Would you consider SBRT and adjuvant therapy for a 4cm, node-negative, non-oncogene driven, NSCLC not amenable to surgical resection?
How would you approach synchronous node positive NSCLC and anal primaries?
In stage II/III node positive patients with driver mutations positive NSCLC who are not surgical candidates and are unlikely to tolerate concurrent chemotherapy and radiation, would you consider radiation alone, TKI alone, or would you ever consider TKI + RT?
Do you apply a tracheal dose constraint during thoracic radiation and/or reirradiation?
Are there situations in which neoadjuvant chemoimmunotherapy + surgery would be preferred over chemoradiation + adjuvant immunotherapy for stage III lung cancer?
What radiation lung dose constraints should be used for a standard fractionation plan in patients recovering from recent immunotherapy induced pneumonitis?
How do you approach salvage for a local/marginal failure after IR ablation for medically inoperable stage I NSCLC?
How do you prescribe a steroid taper for radiation and IO related pneumonitis?
How do you approach at-risk draining nodes and the bronchial stump in PORT volumes for margin-positive, pN0 NSCLC?
Would you treat an in-field recurrence/marginal recurrence of NSCLC following previous definitive chemoradiation with salvage SBRT?